LY353381hydrochloride

Known as: LY353381.HCL, LY353381 hydrochloride, SERM-3 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2006
Review
2006
Hormone-sensitive tumours are among the most common cancers in women. Specific inhibition of the estrogen receptor by selective… (More)
Is this relevant?
Review
2002
Review
2002
The median survival of women with advanced or recurrent endometrial cancer is less than one year. Only half the women with early… (More)
Is this relevant?
2001
2001
PURPOSE We conducted this phase I trial to determine the safety and toxicity profile of LY353381.HCl-a novel, potent, third… (More)
Is this relevant?
2001
2001
PURPOSE Arzoxifene (Arzox) is a novel benzothiophene analogue with selective estrogen receptor modulator activity similar to… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2001
2001
62 Estrogen replacement in ovariectomized rats reduces cerebral tissue infarction sustained after experimental stroke. We… (More)
Is this relevant?
2000
2000
BACKGROUND AND PURPOSE The impact of postmenopausal estrogen replacement therapy on stroke prevention and stroke severity remains… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Review
2000
Review
2000
The median survival of women with advanced or recurrent endometrial cancer is less than one year. Of the women with early stage… (More)
Is this relevant?
Review
2000
Review
2000
Selective oestrogen receptor modulators (SERMs) are structurally diverse non-steroidal compounds that bind to oestrogen receptors… (More)
  • figure 1
  • table I
  • table II
  • table III
Is this relevant?
1998
1998
Body weight, uteri, serum cholesterol and bones were shown previously in vivo to be sensitive to circulating levels of estrogen… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 6
Is this relevant?